StockData

Seaport Therapeutics, Inc. (SPTX) stock

SPTXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 2, 2026
$18.31+0.14 (+0.77%)

Close on Nov 18, 2026Market cap $980.14MP/E –Yield –

Seaport Therapeutics operating income

Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.

Quarterly operating income

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026-$30.35M–
Q2 FY2026Jun 30, 2026-$65.81M–
Q1 FY2026Mar 31, 2026-$27.54M–
Q3 FY2025Sep 30, 2025-$25.44M–
Q2 FY2025Jun 30, 2025-$18.47M–
Q1 FY2025Mar 31, 2025-$16.19M–

More Seaport Therapeutics figures

See a number that looks wrong?